Malassezia Yeasts in Veterinary Dermatology: An Updated Overview

Lipophilic yeasts of the genus Malassezia are important skin commensals and opportunistic skin pathogens in a variety of animals. The species M. pachydermatis was first isolated from the skin of a captive Indian rhinoceros with an exfoliative dermatitis in 1925, recognized as an important otic patho...

Full description

Bibliographic Details
Main Authors: Jacques Guillot, Ross Bond
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2020.00079/full
_version_ 1819169229365051392
author Jacques Guillot
Ross Bond
author_facet Jacques Guillot
Ross Bond
author_sort Jacques Guillot
collection DOAJ
description Lipophilic yeasts of the genus Malassezia are important skin commensals and opportunistic skin pathogens in a variety of animals. The species M. pachydermatis was first isolated from the skin of a captive Indian rhinoceros with an exfoliative dermatitis in 1925, recognized as an important otic pathogen of dogs in the 1950's, and finally accepted, after several years of controversy, as a common cause of canine dermatitis in the 1990's. Since then, there has been considerable research into the biology of Malassezia yeasts and their interaction with their animal hosts. In dogs and cats, M. pachydermatis is associated with ceruminous otitis externa and a “seborrhoeic” dermatitis, wherein pruritic, erythematous skin lesions, often with brown/black greasy, malodourous material matting hairs, preferentially develop in intertriginous areas. Skin disease is favored by folds, underlying hypersensitivity disorders, endocrinopathies, defects of cornification, and in cats, various visceral paraneoplastic syndromes. Diagnosis is based on detecting the yeast in compatible skin lesions, usually by cytology, and observing a clinical and mycological response to therapy. Treatment normally comprises topical or systemic azole therapy, often with miconazole—chlorhexidine shampoos or oral itraconazole or ketoconazole. Management of concurrent diseases is important to minimize relapses. Historically, wild-type Malassezia isolates from dogs and cats were typically susceptible to azoles, with the exception of fluconazole, but emerging azole resistance in field strains has recently been associated with either mutations or quadruplication of the ERG11 gene. These observations have prompted increased interest in alternative topical antifungal drugs, such as chlorhexidine, and various essential oils. Further clinical trials are awaited with interest.
first_indexed 2024-12-22T19:16:11Z
format Article
id doaj.art-0c6557aef90c4a5db210ffa009236c94
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-22T19:16:11Z
publishDate 2020-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-0c6557aef90c4a5db210ffa009236c942022-12-21T18:15:30ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882020-02-011010.3389/fcimb.2020.00079524122Malassezia Yeasts in Veterinary Dermatology: An Updated OverviewJacques Guillot0Ross Bond1École Nationale Vétérinaire d'Alfort, BioPôle Alfort, EA Dynamyc, UPEC, EnvA, Maisons-Alfort, FranceDepartment of Clinical Sciences and Services, Royal Veterinary College, Hatfield, United KingdomLipophilic yeasts of the genus Malassezia are important skin commensals and opportunistic skin pathogens in a variety of animals. The species M. pachydermatis was first isolated from the skin of a captive Indian rhinoceros with an exfoliative dermatitis in 1925, recognized as an important otic pathogen of dogs in the 1950's, and finally accepted, after several years of controversy, as a common cause of canine dermatitis in the 1990's. Since then, there has been considerable research into the biology of Malassezia yeasts and their interaction with their animal hosts. In dogs and cats, M. pachydermatis is associated with ceruminous otitis externa and a “seborrhoeic” dermatitis, wherein pruritic, erythematous skin lesions, often with brown/black greasy, malodourous material matting hairs, preferentially develop in intertriginous areas. Skin disease is favored by folds, underlying hypersensitivity disorders, endocrinopathies, defects of cornification, and in cats, various visceral paraneoplastic syndromes. Diagnosis is based on detecting the yeast in compatible skin lesions, usually by cytology, and observing a clinical and mycological response to therapy. Treatment normally comprises topical or systemic azole therapy, often with miconazole—chlorhexidine shampoos or oral itraconazole or ketoconazole. Management of concurrent diseases is important to minimize relapses. Historically, wild-type Malassezia isolates from dogs and cats were typically susceptible to azoles, with the exception of fluconazole, but emerging azole resistance in field strains has recently been associated with either mutations or quadruplication of the ERG11 gene. These observations have prompted increased interest in alternative topical antifungal drugs, such as chlorhexidine, and various essential oils. Further clinical trials are awaited with interest.https://www.frontiersin.org/article/10.3389/fcimb.2020.00079/fullMalasseziadogcatdiagnosistreatment
spellingShingle Jacques Guillot
Ross Bond
Malassezia Yeasts in Veterinary Dermatology: An Updated Overview
Frontiers in Cellular and Infection Microbiology
Malassezia
dog
cat
diagnosis
treatment
title Malassezia Yeasts in Veterinary Dermatology: An Updated Overview
title_full Malassezia Yeasts in Veterinary Dermatology: An Updated Overview
title_fullStr Malassezia Yeasts in Veterinary Dermatology: An Updated Overview
title_full_unstemmed Malassezia Yeasts in Veterinary Dermatology: An Updated Overview
title_short Malassezia Yeasts in Veterinary Dermatology: An Updated Overview
title_sort malassezia yeasts in veterinary dermatology an updated overview
topic Malassezia
dog
cat
diagnosis
treatment
url https://www.frontiersin.org/article/10.3389/fcimb.2020.00079/full
work_keys_str_mv AT jacquesguillot malasseziayeastsinveterinarydermatologyanupdatedoverview
AT rossbond malasseziayeastsinveterinarydermatologyanupdatedoverview